BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir.
Article in Antimicrobial Agents and Chemotherapy (March 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Antimicrobial Agents and Chemotherapy (March 2024)
Article in Frontiers in Human Neuroscience (November 2023)